期刊
NATURE PROTOCOLS
卷 7, 期 12, 页码 2112-2126出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nprot.2012.131
关键词
-
资金
- Swedish Society of Medical Research (SSMF)
- Wellcome Trust [GR087730]
- Agency of Science, Technology and Research (A*STAR), Singapore
- Medical Research Council [MR/J003360/1, G0900887] Funding Source: researchfish
- Parkinson's UK [G-1109, F-1101] Funding Source: researchfish
- MRC [MR/J003360/1, G0900887] Funding Source: UKRI
The use of small interfering RNAs (siRNAs) to induce gene silencing has opened a new avenue in drug discovery. However, their therapeutic potential is hampered by inadequate tissue-specific delivery. Exosomes are promising tools for drug delivery across different biological barriers. Here we show how exosomes derived from cultured cells can be harnessed for delivery of siRNA in vitro and in vivo. This protocol first describes the generation of targeted exosomes through transfection of an expression vector, comprising an exosomal protein fused with a peptide ligand. Next, we explain how to purify and characterize exosomes from transfected cell supernatant. Next, we detail crucial steps for loading siRNA into exosomes. Finally, we outline how to use exosomes to efficiently deliver siRNA in vitro and in vivo in mouse brain. Examples of anticipated results in which exosome-mediated siRNA delivery is evaluated by functional assays and imaging are also provided. The entire protocol takes similar to 3 weeks.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据